Pharma Pricing and Market Access USA 2018 is a conference and exhibition that covers topics such as:
- Important Market Access trends and updates from across the globe
- New reimbursement models which are impacting market access
- Case studies on demonstrating product value
- Hear from leading international HTA agencies
- How to generate , apply and present real world evidence to maximise patient access
- The payers perspective
- Best practice insights for market access of high value and orphan drugs in the multi speaker focus day
- Pricing and partnering models
- Evidence planning and payer strategy for optimum pricing, market access and launch
Pharma Pricing and Market Access USA 2018 brings together senior attendees with responsibilities in:
- Market Access
- HTA
- Outcomes Research
- Health Economics
- Epidemiology
- Health Policy
- Pharmacoeconomics
- Pricing & Reimbursement
- Clinical research
- Clinical trials
- Medical Affairs
- Post marketing Surveillance
- Pharmacoepidemiology